Prazosin for Agitation in Alzheimer's Disease

Clinical trial NCT03710642 · COMPLETED

Trial details

NCT number: NCT03710642
Sponsor: Alzheimer's Disease Cooperative Study (ADCS)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer's Disease Disruptive Behavior

Start date: 2018-10-23
Primary completion: 2022-01-05
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.